1.03
price down icon3.74%   -0.04
after-market アフターアワーズ: 1.08 0.05 +4.85%
loading
前日終値:
$1.07
開ける:
$1.09
24時間の取引高:
1.28M
Relative Volume:
0.59
時価総額:
$166.67M
収益:
$400.57M
当期純損益:
$9.21M
株価収益率:
25.75
EPS:
0.04
ネットキャッシュフロー:
$146.36M
1週間 パフォーマンス:
+14.84%
1か月 パフォーマンス:
+49.93%
6か月 パフォーマンス:
-46.35%
1年 パフォーマンス:
-76.85%
1日の値動き範囲:
Value
$1.03
$1.11
1週間の範囲:
Value
$0.81
$1.16
52週間の値動き範囲:
Value
$0.5271
$5.205

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
名前
Ironwood Pharmaceuticals Inc
Name
セクター
Healthcare (1157)
Name
電話
617-621-7722
Name
住所
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
職員
253
Name
Twitter
@ironwoodpharma
Name
次回の収益日
2025-02-21
Name
最新のSEC提出書
Name
IRWD's Discussions on Twitter

IRWD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
1.03 173.80M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
154.11 67.83B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.00 46.74B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.52B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.86 20.12B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
313.13 14.11B 2.99B 1.21B 1.13B 25.06

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-15 ダウングレード Jefferies Buy → Hold
2025-04-15 ダウングレード Wells Fargo Overweight → Equal Weight
2025-04-14 ダウングレード Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 開始されました Leerink Partners Market Perform
2024-08-08 ダウングレード CapitalOne Overweight → Equal Weight
2024-01-17 開始されました Craig Hallum Buy
2023-12-14 開始されました Wells Fargo Overweight
2023-11-09 開始されました Jefferies Buy
2023-09-28 開始されました JMP Securities Mkt Outperform
2022-09-02 開始されました CapitalOne Overweight
2022-04-22 開始されました Piper Sandler Overweight
2020-09-30 ダウングレード Wells Fargo Overweight → Equal Weight
2020-06-17 開始されました Northland Capital Outperform
2019-07-10 再開されました Credit Suisse Neutral
2019-03-27 アップグレード Morgan Stanley Underweight → Equal-Weight
2019-02-25 アップグレード H.C. Wainwright Sell → Neutral
2019-01-24 アップグレード JP Morgan Underweight → Neutral
2018-11-07 ダウングレード Credit Suisse Outperform → Neutral
2018-11-07 ダウングレード JP Morgan Neutral → Underweight
2018-07-23 開始されました H.C. Wainwright Sell
2018-05-09 ダウングレード Morgan Stanley Equal-Weight → Underweight
2018-01-05 ダウングレード BofA/Merrill Buy → Underperform
2017-12-06 ダウングレード Mizuho Buy → Neutral
2017-07-21 ダウングレード JP Morgan Overweight → Neutral
2017-05-03 開始されました Wells Fargo Outperform
2017-04-07 繰り返されました Mizuho Buy
2017-02-22 繰り返されました Barclays Equal Weight
2016-11-04 繰り返されました Mizuho Buy
2016-10-24 繰り返されました Wedbush Neutral
2016-10-10 繰り返されました Mizuho Buy
2016-09-27 繰り返されました WallachBeth Hold
すべてを表示

Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース

pulisher
Aug 15, 2025

Multi factor analysis applied to Ironwood Pharmaceuticals Inc.2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Published on: 2025-08-15 04:45:17 - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Can Ironwood Pharmaceuticals Inc. be recession proofJuly 2025 Catalysts & Safe Entry Momentum Tips - classian.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Ironwood Pharmaceuticals Inc. Uptrend in Early Stages Indicators Say YesJuly 2025 Summary & AI Enhanced Trading Signals - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

Published on: 2025-08-14 14:41:22 - beatles.ru

Aug 14, 2025
pulisher
Aug 13, 2025

Sectors Driving Future Growth for Ironwood Pharmaceuticals Inc. StockWeekly Trend Report & Capital Efficiency Focused Strategies - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Can Ironwood Pharmaceuticals Inc. expand its profit margins2025 Performance Recap & Verified Entry Point Detection - 선데이타임즈

Aug 13, 2025
pulisher
Aug 13, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: 89bio (ETNB), Relay Therapeutics (RLAY) and Ironwood Pharma (IRWD) - The Globe and Mail

Aug 13, 2025
pulisher
Aug 12, 2025

Risk adjusted return profile for Ironwood Pharmaceuticals Inc. analyzedFree Swing Trading Plan With Smart Signals - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Historical volatility pattern of Ironwood Pharmaceuticals Inc. visualizedJuly 2025 Momentum & Daily Profit Focused Screening - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Volume spikes in Ironwood Pharmaceuticals Inc. stock – what they meanSmart Entry Signals for Active Traders - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Short Bowel Syndrome Market to Experience Notable Growth - openPR.com

Aug 12, 2025
pulisher
Aug 12, 2025

Short Bowel Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Zealand Pharma, Ironwood Pharma, Hanmi Pharma, Shire, AbbVie, Hanmi Pharma - Barchart.com

Aug 12, 2025
pulisher
Aug 12, 2025

How high can Ironwood Pharmaceuticals Inc. stock goSmart Entry Signals for Active Traders - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Ironwood Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 11, 2025
pulisher
Aug 08, 2025

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates - Yahoo Finance

Aug 08, 2025
pulisher
Aug 08, 2025

Ironwood: Q2 Earnings Snapshot - Connecticut Post

Aug 08, 2025
pulisher
Aug 08, 2025

Ironwood Pharmaceuticals Reports Strong Q2 2025 Results - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

Ironwood (IRWD) Q2 EPS Jumps 600% - AOL.com

Aug 07, 2025
pulisher
Aug 07, 2025

Ironwood Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Ironwood Pharmaceuticals (IRWD.O) Surges 15.5% on Strong KDJ Signal Amid Mixed Peer Performance - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance - BioSpace

Aug 07, 2025
pulisher
Aug 07, 2025

Ironwood Pharmaceuticals Q2 2025 Earnings: EPS of $0.15 and Reve - GuruFocus

Aug 07, 2025
pulisher
Aug 07, 2025

Ironwood Pharmaceuticals Tops Expectations With Strong Q2 Results - Finimize

Aug 07, 2025
pulisher
Aug 07, 2025

Ironwood Pharmaceuticals (IRWD) Projected to Post Quarterly Earnings on Thursday - Defense World

Aug 07, 2025
pulisher
Aug 06, 2025

Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail

Aug 06, 2025
pulisher
Aug 04, 2025

Ironwood Pharmaceuticals Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView

Aug 04, 2025
pulisher
Aug 04, 2025

Custom Dashboard Highlights Ironwood Pharmaceuticals Inc. Price MomentumFundamental Growth Stock Analysis Shows Strength - beatles.ru

Aug 04, 2025
pulisher
Aug 03, 2025

Published on: 2025-08-04 00:15:09 - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Ironwood Pharmaceuticals Inc. stock priceExpert guidance for superior capital growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Ironwood Pharmaceuticals Inc. stock overvalued or undervaluedAchieve rapid portfolio growth with expert guidance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Ironwood Pharmaceuticals Inc. stockOutstanding risk-reward balance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Ironwood Pharmaceuticals Inc. a growth stock or a value stockDiscover stocks with strong growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Ironwood Pharmaceuticals Inc.Build a winning investment strategy - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Ironwood Pharmaceuticals Inc.Unprecedented growth rates - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Ironwood Pharmaceuticals Inc. stock higher in 2025Achieve breakthrough financial growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Ironwood Pharmaceuticals Inc. company’s balance sheetDynamic portfolio growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Ironwood Pharmaceuticals Inc. stock price move sharplyExceptional financial outcomes - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What Fibonacci levels say about Ironwood Pharmaceuticals Inc. reboundAutomated AI Forecast with Trading Alerts - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

Earnings visualization tools for Ironwood Pharmaceuticals Inc.Market Stability and Long-Term Growth Outlook - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

What is the risk reward ratio of investing in Ironwood Pharmaceuticals Inc. stockStock Market Picks With High Returns - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Evaluating Ironwood Pharmaceuticals Inc. with trendline analysisSummary of Consistent Growth Stock Picks - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

How hedge fund analytics apply to Ironwood Pharmaceuticals Inc. stockAI Driven Buy Alert Trade Blueprint Released - metal.it

Jul 31, 2025
pulisher
Jul 30, 2025

Exit strategy if you’re trapped in Ironwood Pharmaceuticals Inc.2025 Market Trends & Long Hold Capital Preservation Plans - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Ironwood Pharmaceuticals Inc. Recovery Likely Here’s What Data ShowsReal Time Alerts Based on AI Prediction Triggered - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Heatmap Data Shows High Activity in Ironwood Pharmaceuticals Inc. SectorAccurate Buy Point for Momentum Stocks Detected - metal.it

Jul 29, 2025

Ironwood Pharmaceuticals Inc (IRWD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$29.05
price up icon 2.80%
$17.96
price down icon 0.22%
drug_manufacturers_specialty_generic RDY
$14.22
price up icon 0.78%
$10.61
price down icon 0.75%
$132.90
price up icon 1.21%
$313.13
price up icon 0.34%
大文字化:     |  ボリューム (24 時間):